Your browser doesn't support javascript.
loading
Simvastatin improves olanzapine-induced dyslipidemia in rats through inhibiting hepatic mTOR signaling pathway.
Liu, Xue-Mei; Zhao, Xiao-Min; Deng, Chao; Zeng, Yan-Ping; Hu, Chang-Hua.
Afiliação
  • Liu XM; School of Pharmaceutical Sciences, Southwest University, Chongqing 400715, China.
  • Zhao XM; Engineer Research Center of Chongqing Pharmaceutical Process and Quality Control, Chongqing 400715, China.
  • Deng C; School of Pharmaceutical Sciences, Southwest University, Chongqing 400715, China.
  • Zeng YP; School of Medicine, University of Wollongong, Wollongong, 2522, NSW, Australia.
  • Hu CH; Antipsychotic Research Laboratory, Illawarra Health and Medical Research Institute, Wollongong, 2522, NSW, Australia.
Acta Pharmacol Sin ; 40(8): 1049-1057, 2019 Aug.
Article em En | MEDLINE | ID: mdl-30728467

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Sinvastatina / Dislipidemias / Serina-Treonina Quinases TOR Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Sinvastatina / Dislipidemias / Serina-Treonina Quinases TOR Idioma: En Ano de publicação: 2019 Tipo de documento: Article